Form 4: Liquidia CHRO Sells Shares for Tax Obligations

Liquidia Corp's Chief Human Resource Officer, Sarah Krepp, sold 209 shares of common stock at $29.05 per share to cover tax liabilities from RSU settlement.

Summary

• Sarah Krepp, Liquidia Corp's Chief Human Resource Officer, reported a sale of 209 shares of common stock.
• The transaction occurred on August 29, 2025, at a price of $29.05 per share.
• The sale was executed under a Rule 10b5-1 plan established on December 15, 2023.
• The purpose of the sale was to cover tax obligations related to the settlement of restricted stock units (RSUs).
• Following this transaction, Ms. Krepp beneficially owns 143,130 shares directly.
• This beneficial ownership includes 36,540 unvested RSUs from a January 11, 2024 grant, 9,344 unvested RSUs from a July 1, 2024 grant, 50,861 unvested RSUs from a January 11, 2025 grant, 25,000 unvested RSUs from a July 1, 2025 grant, and 5,312 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.

Sentiment

Score: 7

Explanation: The transaction is a routine tax-related sale under a 10b5-1 plan, which is generally neutral to slightly positive as it's not a discretionary sale indicating lack of confidence. The officer retains substantial equity, including significant unvested RSUs.

Positives

• The sale was for tax-related purposes, which is a routine event for RSU vesting and not indicative of a lack of confidence in the company.
• The transaction was conducted under a pre-arranged Rule 10b5-1 plan, demonstrating planned and compliant trading.
• The officer retains a significant beneficial ownership of 143,130 shares, including a substantial number of unvested RSUs, aligning her interests with long-term shareholder value.

Negatives

• A reduction in direct share ownership, even if for tax purposes, slightly decreases the officer's direct equity stake.

Future Outlook

The filing does not provide specific forward-looking statements or guidance beyond the scheduled vesting of restricted stock units.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction, common across all industries, particularly for executives receiving equity compensation. It does not provide specific insights into broader industry trends for the biotechnology or pharmaceutical sector where Liquidia Corp operates.

Comparison to Industry Standards

• The sale of shares to cover tax obligations upon RSU vesting is a standard practice for executive compensation across publicly traded companies.
• This type of transaction is not typically compared to specific industry benchmarks or competitor activities as it reflects individual compensation management rather than strategic corporate performance.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a small, routine tax-related sale. The officer's continued significant beneficial ownership aligns interests.
• Employees: No direct impact mentioned.

Next Steps

• Continued vesting of various restricted stock unit grants on their respective schedules.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of a small number of shares by an executive to cover tax obligations upon RSU vesting, executed under a pre-established 10b5-1 plan. Such a transaction typically has no material impact on the company's fundamentals or future prospects and does not signal a change in management's confidence. The executive retains a substantial equity stake, including significant unvested RSUs. Therefore, the filing itself does not provide a basis for a change in investment recommendation; a 'hold' stance is appropriate, pending further fundamental analysis of the company's operations and financial performance.

Keywords

Liquidia Corp, LQDA, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU, Tax Obligations, Rule 10b5-1, Executive Compensation